Authors: Moutquin, JM Cabrol, D Fisk, NM MacLennan, AH Marsal, K Rabinovici, J

Citation: Jm. Moutquin et al., Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour, BR J OBST G, 108(2), 2001, pp. 133-142

Authors: Brown, MA Lindheimer, MD de Swiet, M Van Assche, A Moutquin, JM

Citation: Ma. Brown et al., The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP), HYPERTENS P, 20(1), 2001, pp. IX-XIV

Authors: Levine, M Moutquin, JM Walton, R Feightner, J

Citation: M. Levine et al., Give us clear, not convoluted, clinical practice guidelines - response, CAN MED A J, 165(11), 2001, pp. 1469-1469

Authors: Levine, M Moutquin, JM Walton, R Feightner, J

Citation: M. Levine et al., Chemoprevention of breast cancer - A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer, CAN MED A J, 164(12), 2001, pp. 1681-1690

Authors: Moutquin, JM Sherman, D Cohen, H Mohide, PT Hochner-Celnikier, D Fejgin, M Liston, RM Dansereau, J Mazor, M Shalev, E Boucher, M Glezerman, M Zimmer, EZ Rabinovici, J

Citation: Jm. Moutquin et al., Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: A multicenter effectiveness and safety study, AM J OBST G, 182(5), 2000, pp. 1191-1199

Authors: Irion, O Masse, J Forest, JC Moutquin, JM

Citation: O. Irion et al., Prediction of pre-eclampsia, low birthweight for gestational age and prematurity by uterine artery blood flow velocity waveforms in low risk nulliparous women - Reply, BR J OBST G, 106(1), 1999, pp. 89-89